Home
NICE Guidance
Conditions and diseases
Cystic fibrosis
Lumacaftor–ivacaftor for treating cystic fibrosis homozygous for the F508del mutation
Technology appraisal guidance [TA398]
Published:
27 July 2016
Guidance
Tools and resources
Information for the public
History
Do no do examples
Do no do examples for Lumacaftor–ivacaftor for treating cystic fibrosis homozygous for the F508del mutation
Title
Year published
Impact Level
No results could be found